Posted inNews and Updates
US FDA Issues Five Observations to Eugia Steriles Facility
Aurobindo Pharma’s subsidiary, Eugia Steriles, has received five US FDA observations following a site inspection. Learn the implications for production.
Posted inNews and Updates
UK Sets 11 as Minimum Age for Puberty Blocker Trials
The UK has set a minimum age of 11 for puberty blocker trials. Learn about the new safety protocols and evidence-based approach to pediatric gender-affirming care.
Posted inNews and Updates
FDA Approves Skinvive by Juvéderm to Treat Neck Wrinkles
The FDA has expanded the approval of Skinvive by Juvéderm to treat neck wrinkles. Learn how this hyaluronic acid injectable improves skin smoothness.
Posted inNews and Updates
Stem Cell Therapy Market Projected to Reach $3.65B by 2030
The global stem cell therapy market is set to reach $3.65B. Discover the key innovations and market trends driving this rapid growth in regenerative medicine.
Posted inNews and Updates
Teva Seeks FDA Approval for Ecopipam to Treat Tourette’s
Teva has submitted an NDA for ecopipam, a novel D1 receptor antagonist, to treat pediatric Tourette syndrome. Learn about this potential new therapy.
Posted inNews and Updates
Urgent Call for FDA Vaccine Pathway for Dementia Prevention
Experts urge the FDA to create a dedicated regulatory pathway for vaccine-based dementia prevention trials to accelerate breakthroughs in neuro-immunology.
Posted inNews and Updates
FDA Approves CAPVAXIVE for High-Risk Children and Teens
The USFDA has approved CAPVAXIVE for children and teens at high risk of pneumococcal disease. Learn about this new vaccine's role in pediatric prevention.
Posted inNews and Updates
Paid Paternity Leave Linked to Better Mental Health
New research reveals that paid paternity leave significantly lowers depression and stress in new fathers, fostering stronger family health and wellbeing.
Posted inNews and Updates
Cervical Cancer Deaths Plummet to Zero in Vaccinated Women
New data confirms zero cervical cancer deaths in women vaccinated against HPV in England, highlighting the life-saving impact of immunization programs.
Posted inNews and Updates
HHS Issues New Labeling Requirements for Testosterone Drugs
HHS has mandated critical safety label updates for testosterone therapy drugs to improve patient safety, clinical monitoring, and reduce misuse risks.